A
Aveo Pharmaceuticals Inc
F:VPA1
Aveo Pharmaceuticals Inc
F:VPA1
Price:
13.77
EUR
-0.4%
Market Closed
Market Cap:
€478.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aveo Pharmaceuticals Inc
F:VPA1
|
US |
|
P
|
Panda Financial Holding Corp Ltd
SSE:600599
|
CN |
|
Maha Energy AB
STO:MAHA A
|
SE |
|
H
|
HKScan Oyj
OMXH:HKSAV
|
FI |
|
Zhuhai Huafa Properties Co Ltd
SSE:600325
|
CN |
|
Harboes Bryggeri A/S
CSE:HARB B
|
DK |
Income Statement
Earnings Waterfall
Aveo Pharmaceuticals Inc
Aveo Pharmaceuticals Inc
Income Statement
Aveo Pharmaceuticals Inc
Aveo Pharmaceuticals Inc
Currency: USD
| Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Revenue |
19
N/A
|
19
-3%
|
17
-9%
|
16
-4%
|
1
-93%
|
16
+1 250%
|
18
+9%
|
18
+3%
|
18
-1%
|
3
-84%
|
1
-59%
|
16
+1 192%
|
19
+23%
|
20
+6%
|
20
+0%
|
6
-70%
|
3
-58%
|
4
+52%
|
4
+5%
|
8
+90%
|
8
N/A
|
6
-20%
|
6
N/A
|
4
-34%
|
5
+35%
|
6
+11%
|
6
+5%
|
30
+368%
|
29
-2%
|
28
-3%
|
28
N/A
|
6
-79%
|
6
+2%
|
7
+18%
|
14
+97%
|
26
+83%
|
42
+66%
|
61
+45%
|
79
+29%
|
94
+19%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(3)
|
(5)
|
(7)
|
(9)
|
(11)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
9
+374%
|
22
+157%
|
38
+71%
|
54
+44%
|
70
+29%
|
83
+19%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(128)
|
(128)
|
(121)
|
(114)
|
(97)
|
(81)
|
(72)
|
(61)
|
(57)
|
(46)
|
(36)
|
(29)
|
(27)
|
(30)
|
(32)
|
(32)
|
(32)
|
(34)
|
(36)
|
(36)
|
(34)
|
(32)
|
(31)
|
(32)
|
(32)
|
(33)
|
(31)
|
(30)
|
(29)
|
(31)
|
(34)
|
(39)
|
(45)
|
(54)
|
(68)
|
(79)
|
(87)
|
(94)
|
(101)
|
(107)
|
|
| Selling, General & Administrative |
(34)
|
(38)
|
(36)
|
(31)
|
(29)
|
(22)
|
(19)
|
(20)
|
(19)
|
(16)
|
(14)
|
(12)
|
(14)
|
(14)
|
(12)
|
(12)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(13)
|
(13)
|
(16)
|
(22)
|
(34)
|
(45)
|
(54)
|
(61)
|
(63)
|
(65)
|
(68)
|
|
| Research & Development |
(94)
|
(90)
|
(85)
|
(83)
|
(69)
|
(59)
|
(52)
|
(42)
|
(38)
|
(29)
|
(22)
|
(18)
|
(13)
|
(16)
|
(20)
|
(20)
|
(24)
|
(26)
|
(27)
|
(27)
|
(25)
|
(23)
|
(21)
|
(21)
|
(21)
|
(22)
|
(20)
|
(19)
|
(18)
|
(19)
|
(21)
|
(23)
|
(23)
|
(21)
|
(23)
|
(25)
|
(26)
|
(31)
|
(36)
|
(40)
|
|
| Operating Income |
(109)
N/A
|
(109)
0%
|
(104)
+5%
|
(98)
+6%
|
(96)
+2%
|
(65)
+32%
|
(54)
+17%
|
(43)
+20%
|
(39)
+10%
|
(43)
-10%
|
(35)
+18%
|
(14)
+61%
|
(8)
+41%
|
(9)
-18%
|
(12)
-27%
|
(26)
-118%
|
(29)
-13%
|
(30)
-2%
|
(32)
-6%
|
(28)
+11%
|
(27)
+5%
|
(26)
+3%
|
(25)
+6%
|
(28)
-13%
|
(26)
+6%
|
(27)
-3%
|
(24)
+9%
|
0
N/A
|
(0)
N/A
|
(3)
-1 000%
|
(6)
-76%
|
(33)
-466%
|
(39)
-19%
|
(47)
-22%
|
(55)
-16%
|
(56)
-2%
|
(50)
+12%
|
(39)
+20%
|
(32)
+20%
|
(24)
+22%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(2)
|
3
|
2
|
(21)
|
(46)
|
(36)
|
(37)
|
(2)
|
5
|
18
|
28
|
19
|
34
|
10
|
4
|
2
|
4
|
3
|
(2)
|
(1)
|
(1)
|
(4)
|
(2)
|
(5)
|
(5)
|
|
| Non-Reccuring Items |
(3)
|
(3)
|
(11)
|
(11)
|
(8)
|
(12)
|
(9)
|
(11)
|
(12)
|
(12)
|
(7)
|
(6)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(114)
N/A
|
(115)
-1%
|
(118)
-2%
|
(112)
+5%
|
(107)
+4%
|
(79)
+26%
|
(66)
+18%
|
(56)
+15%
|
(53)
+5%
|
(57)
-8%
|
(45)
+22%
|
(22)
+50%
|
(15)
+33%
|
(12)
+22%
|
(15)
-26%
|
(28)
-87%
|
(27)
+4%
|
(28)
-4%
|
(53)
-88%
|
(74)
-40%
|
(65)
+12%
|
(65)
0%
|
(28)
+57%
|
(24)
+15%
|
(5)
+77%
|
4
N/A
|
(3)
N/A
|
36
N/A
|
9
-74%
|
0
-96%
|
(4)
N/A
|
(29)
-653%
|
(36)
-24%
|
(49)
-38%
|
(56)
-13%
|
(58)
-4%
|
(53)
+7%
|
(41)
+22%
|
(36)
+13%
|
(29)
+20%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(114)
|
(115)
|
(118)
|
(112)
|
(107)
|
(79)
|
(66)
|
(56)
|
(53)
|
(57)
|
(45)
|
(22)
|
(15)
|
(12)
|
(15)
|
(28)
|
(27)
|
(28)
|
(53)
|
(74)
|
(65)
|
(65)
|
(28)
|
(24)
|
(5)
|
4
|
(3)
|
36
|
9
|
0
|
(4)
|
(29)
|
(36)
|
(49)
|
(56)
|
(58)
|
(53)
|
(41)
|
(36)
|
(29)
|
|
| Net Income (Common) |
(114)
N/A
|
(115)
-1%
|
(118)
-2%
|
(112)
+5%
|
(107)
+4%
|
(79)
+26%
|
(66)
+18%
|
(56)
+15%
|
(53)
+5%
|
(57)
-8%
|
(45)
+22%
|
(22)
+50%
|
(15)
+33%
|
(12)
+21%
|
(15)
-26%
|
(28)
-86%
|
(27)
+4%
|
(28)
-4%
|
(53)
-88%
|
(74)
-41%
|
(65)
+12%
|
(65)
0%
|
(28)
+57%
|
(24)
+15%
|
(5)
+77%
|
4
N/A
|
(3)
N/A
|
36
N/A
|
9
-74%
|
0
-96%
|
(4)
N/A
|
(29)
-653%
|
(36)
-24%
|
(49)
-38%
|
(56)
-13%
|
(58)
-4%
|
(53)
+7%
|
(41)
+22%
|
(36)
+13%
|
(29)
+20%
|
|
| EPS (Diluted) |
-26.58
N/A
|
-23.51
+12%
|
-23.06
+2%
|
-21.92
+5%
|
-20.58
+6%
|
-15.27
+26%
|
-12.6
+17%
|
-10.69
+15%
|
-9.78
+9%
|
-10.79
-10%
|
-7.45
+31%
|
-3.93
+47%
|
-2.6
+34%
|
-2.05
+21%
|
-2.24
-9%
|
-3.67
-64%
|
-3.54
+4%
|
-3.68
-4%
|
-4.75
-29%
|
-6.28
-32%
|
-5.51
+12%
|
-5.48
+1%
|
-2.16
+61%
|
-1.98
+8%
|
-0.44
+78%
|
0.32
N/A
|
-0.18
N/A
|
2.22
N/A
|
0.58
-74%
|
0.02
-97%
|
-0.22
N/A
|
-1.11
-405%
|
-1.35
-22%
|
-1.8
-33%
|
-1.62
+10%
|
-1.67
-3%
|
-1.55
+7%
|
-1.2
+23%
|
-1.05
+12%
|
-0.84
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
